1994
Small Grants Proposal Review Committee, University
of Massachusetts School of Medicine
1996
Abstract Reviewer, American Heart Association,
68th Scientific Sessions
1998
Clinical Events Committee, TIMI 16-OPUS Trial
2000
Data and Safety Monitoring Committee: XaNADU:
Xa Neutralization for Atherosclerotic Disease Understanding.
A dose ranging trial of DX-9065a vs. placebo to determine
the pharmacokinetics, pharmacodynamics, safety profile,
and biochemical marker relationships in older patients with
coronary artery disease.
2001
ATF2459g Scientific Advisory Board, Genentech,
Inc
2001
Member, editorial board Journal of the American
College of Cardiology
